# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Amit Dayal reiterates Calumet Specialty Prods (NASDAQ:CLMT) with a Buy and maintains $25 pri...
Goldman Sachs analyst Neil Mehta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Buy and lowers the price target from...
Calumet reported Q4 sales decline of 2.3%, beating consensus. Gross profit down 38.3%. Plans to convert to C-Corp by 2024. Mont...
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimat...
Companies Reporting Before The Bell • Fomento Economico (NYSE:FMX) is likely to report quarterly earnings at $1.61 per share o...
Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) ("Calumet," "the Partnership," "we," or "us...
Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) (the "Partnership," "Calumet," "Company," "...
Goldman Sachs analyst Neil Mehta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Buy and raises the price target from...